MRD-directed risk stratification treatment may improve outcomes of t(8;21) AML in the first complete remission: results from the AML05 multicenter trial

Hong‐Hu Zhu, Xiaohui Zhang, Ya‐Zhen Qin, +19

Blood

Sunlight-driven simultaneous CO2 reduction and water oxidation using indium-organic framework heterostructures

Zhongjie Cai, Hongwei Liu, Jiajun Dai, +4

Nature Communications

CXCR4 is a good survival prognostic indicator in multiple myeloma patients

Li Bao, Yue‐Yun Lai, Yanrong Liu, +6

Leukemia Research

Hematological MalignancyMedicinePrognosisHematologyPathology +5

CD34 expression on bone marrow blasts is a novel predictor of poor prognosis independent of FlT3-ITD in acute myeloid leukemia with the NPM1-mutation

Hong‐Hu Zhu, Yanrong Liu, Hao Jiang, +7

Leukemia Research

Hematological MalignancyMedicineAcute Myeloid LeukemiaMixed-phenotype Acute LeukemiaImmunology +7

P144, A TGF-β1 Antagonist Peptide, Synergizes with Sildenafil and Enhances Erectile Response via Amelioration of Cavernosal Fibrosis in Diabetic Rats

Wen Ji Li, Hao Wang, Juan Zhou, +4

The Journal of Sexual Medicine

Herlyn–Werner–Wunderlich syndrome: diverse presentations and diagnosis on MRI

Hao Zhang, Gang Ning, Chuan Fu, +2

Clinical Radiology

HistopathologyDiagnosisDiverse PresentationsRadiologic ImagingNeuropathology +4

Exploring the stage-specific roles of Tcf-1 in T cell development and malignancy at single-cell resolution

Fang Wang, Zhihong Qi, Yingpeng Yao, +8

Cellular and Molecular Immunology

T Cell DevelopmentCancer ImmunosurveillanceLymphocyte DevelopmentSingle-cell ResolutionT-regulatory Cell +10

Validation of residual SYNTAX score with second-generation drug-eluting stents: one-year results from the prospective multicentre SEEDS study

Bo Xu, Yuejin Yang, Yaling Han, +8

EuroIntervention

CD27 antigen negative expression indicates poor prognosis in newly diagnosed multiple myeloma

Bin Chu, Li Bao, Yutong Wang, +6

Clinical Immunology

Hematological MalignancyMedicineHematologyImmunologyPathology +6

Ixazomib-based frontline therapy in patients with newly diagnosed multiple myeloma in real-life practice showed comparable efficacy and safety profile with those reported in clinical trial: a multi-center study

Jing Li, Li Bao, Zhongjun Xia, +17

Annals of Hematology